Wednesday October 18th 2017

Biogen’s Tecfidera approved in Europe, first launch expected in Germany

Biogen Idec has received approval to launch its soon-to-be blockbuster multiple sclerosis drug, Tecfidera, in Europe, and plans to begin with a launch in Germany in the coming weeks. Approval was widely expected after a committee of the European Medicines Agency voted in favor of the oral pill last November, but the launch was delayed as the Cambridge, Mass.-based company sought 10 extra years of protection there before generic versions of the drug would be allowed. Besides U.S. approval last March,… (Source: bizjournals.com Health Care:Biotechnology headlines)

Read article here: 

Biogen’s Tecfidera approved in Europe, first launch expected in Germany

Leave a Comment

More from category

Discovery may lead to new approach for treating MS
Discovery may lead to new approach for treating MS

Around 2.5 million people are affected by the autoimmune disease Multiple Sclerosis (MS), the commonest central nervous [Read More]

Roche to present new OCREVUS (ocrelizumab) efficacy and safety data in relapsing and primary progressive forms of multiple sclerosis at ECTRIMS
Roche to present new OCREVUS (ocrelizumab) efficacy and safety data in relapsing and primary progressive forms of multiple sclerosis at ECTRIMS

Roche announced today that new data on OCREVUS ® (ocrelizumab) in people with relapsing and primary progressive forms [Read More]

All you need to know about dysesthesia
All you need to know about dysesthesia

Dysesthesia is a painful, itchy sensation, often associated with multiple sclerosis (MS). Learn more about the symptoms [Read More]

Medical News Today: All you need to know about dysesthesia
Medical News Today: All you need to know about dysesthesia

Dysesthesia is a painful, itchy sensation, often associated with multiple sclerosis (MS). Learn more about the symptoms [Read More]

MRI brain scans can reveal MS risk in children before clinical symptoms appear
MRI brain scans can reveal MS risk in children before clinical symptoms appear

By the time multiple sclerosis (MS) is diagnosed in children, it may be difficult to prevent the disabilities and [Read More]